CATAFLAM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cataflam, and what generic alternatives are available?
Cataflam is a drug marketed by Amici and Novartis and is included in two NDAs.
The generic ingredient in CATAFLAM is diclofenac potassium. There are forty-seven drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the diclofenac potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cataflam
A generic version of CATAFLAM was approved as diclofenac potassium by TEVA on August 6th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CATAFLAM?
- What are the global sales for CATAFLAM?
- What is Average Wholesale Price for CATAFLAM?
Summary for CATAFLAM
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 58 |
| Clinical Trials: | 15 |
| Patent Applications: | 4,575 |
| DailyMed Link: | CATAFLAM at DailyMed |
Recent Clinical Trials for CATAFLAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cairo University | Phase 4 |
| Pharmactive Ilac Sanayi ve Tic A.S. | Phase 1/Phase 2 |
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 |
Pharmacology for CATAFLAM
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
| Physiological Effect | Decreased Prostaglandin Production |
US Patents and Regulatory Information for CATAFLAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amici | CATAFLAM | diclofenac potassium | TABLET;ORAL | 076561-002 | Jul 21, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Novartis | CATAFLAM | diclofenac potassium | TABLET;ORAL | 020142-002 | Nov 24, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Amici | CATAFLAM | diclofenac potassium | TABLET;ORAL | 076561-001 | Mar 18, 2004 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Novartis | CATAFLAM | diclofenac potassium | TABLET;ORAL | 020142-001 | Nov 24, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
